ID News Round-Up: COVID-19 Prevention and Treatment
US health officials are predicting a new wave of COVID-19 infections in the fall, and the Food and Drug Administration (FDA) has issued new guidance on COVID-19 vaccines and treatments. Read recent news of interest from the world of infectious diseases, with a focus on COVID-19 prevention and treatment …
2022 Annual Conference on Vaccinology Research: News Round-Up
Researchers, scientists, and public health professionals from around the world participated in the online 2022 Annual Conference on Vaccinology Research (ACVR) hosted by the National Foundation for Infectious Diseases (NFID) on April 11-12, 2022 …
ID News Round-Up: Additional COVID-19 Boosters
The Food and Drug Administration (FDA) recently authorized a second booster dose of COVID-19 vaccine for adults age 50 years and older and certain individuals who have undergone solid organ transplants or who have other conditions that weaken their immune systems. Soon after, the Centers for Disease Control and Prevention (CDC) updated its guidance to reflect the expanded eligibility. Read recent news of interest from the world of infectious diseases, with a focus on COVID-19 booster doses …
Schaffner Report: Facing the Mask Question Head On
The Centers for Disease Control and Prevention (CDC) recently updated COVID-19 guidance on masking and launched a new tool to help communities decide what prevention measures to take based on the latest data. In this episode of the Schaffner Report, William Schaffner, MD, medical director of the National Foundation for Infectious Diseases (NFID) talks with NFID Executive Director and CEO Marla Dalton, CAE, about current masking guidance, COVID-19 community levels, and whether we should continue wearing masks …
ID News Round-Up: To Mask or Not To Mask?
The Centers for Disease Control and Prevention (CDC) recently updated its guidance on masking. Read recent news of interest from the world of infectious diseases, with a focus on COVID-19 and a new tool (COVID-19 Community Level) to determine appropriate prevention steps based on the latest data …
Short on Time?
Coadministration of COVID-19 vaccines at the same time as other recommended vaccines is safe and convenient. Help spread awareness with these resources …
The Impact of Disparities on Health Outcomes
February is Black History Month, a time to reflect on the past and look toward the future of Black communities. It’s also a time to address persistent health disparities that continue to result in poor health outcomes among communities of color …
ID News Round-Up: COVID-19 Boosters, Tests, Masks, and a New Subvariant
A new subvariant of Omicron has been detected, and public health experts continue to evaluate long-term strategies for curbing the COVID-19 pandemic. Read recent news of interest from the world of infectious diseases, with a focus on COVID-19 and what you should know about the new subvariant, at-home tests, masks, and how to tell the difference between COVID-19 symptoms and other respiratory illnesses …
Schaffner Report: Insights on Updated COVID-19 Guidance
With the Omicron variant on the rise and ongoing changes in public health guidance as the science evolves, it is not surprising that there are many questions about what to do to help stop the spread of COVID-19. In this episode of the Schaffner Report, William Schaffner, MD, medical director of the National Foundation for Infectious Diseases (NFID), talks with NFID Executive Director & CEO Marla Dalton about the latest guidance around COVID-19 vaccine booster doses, masks, quarantine, and testing, as well as the rationale for the recommendations.
Top 5 Webinar Resources to Increase Vaccination Rates
From COVID-19 updates to new vaccination recommendations, NFID webinars provide healthcare professionals with timely information and practical strategies to help increase vaccination rates. Read on for the top 5 NFID webinars from 2021, all of which are available on-demand, at no cost …
Schaffner Report: Widening Circle of Eligibility for COVID-19 Boosters
The widening circle of eligibility for COVID-19 vaccine booster doses has expanded once again and now includes all adults age 18 years and older. In this episode of the Schaffner Report, NFID Medical Director William Schaffner, MD, talks with NFID Executive Director & CEO Marla Dalton to share important information about the new booster recommendations …
Schaffner Report: COVID-19 Boosters and Vaccines for Children
Millions of US adults are newly eligible for COVID-19 booster shots, and—at long last—children age 5-11 years can now get vaccinated for COVID-19.
In this episode of the Schaffner Report, NFID Medical Director William Schaffner, MD, talks with NFID Executive Director & CEO Marla Dalton to help put it all into context …
